永赢中证全指医疗器械ETF(159883)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
-79,899,795.42 |
-267,798,441.06 |
-174,590,578.28 |
-189,835,940.66 |
| 本期利润 |
-15,600,340.74 |
-285,034,889.08 |
-353,920,871.03 |
-308,671,495.96 |
| 加权平均基金份额本期利润 |
0.00 |
-0.08 |
-0.10 |
-0.08 |
| 本期加权平均净值利润率(%) |
-0.93 |
-16.34 |
-19.50 |
-13.84 |
| 本期基金份额净值增长率(%) |
-0.89 |
-13.99 |
-16.71 |
-12.62 |
| 期末可供分配利润 |
-1,963,431,582.99 |
-1,830,008,213.01 |
-1,805,468,678.09 |
-1,900,804,855.89 |
| 期末可供分配基金份额利润 |
-0.52 |
-0.52 |
-0.53 |
-0.44 |
| 期末基金资产净值 |
1,816,606,260.01 |
1,723,029,629.99 |
1,598,569,164.91 |
2,457,232,987.11 |
| 期末基金份额净值 |
0.48 |
0.48 |
0.47 |
0.56 |
| 基金份额累计净值增长率(%) |
-51.94 |
-51.51 |
-53.04 |
-43.62 |
微信公众号
证券之星APP
基本资料
